Bryan M. Reasons Insider Trading $MNK Mallinckrodt plc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Bryan M. Reasons.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Bryan M. Reasons. Bryan M. Reasons is Chief Financial Officer in IMPAX LABORATORIES INC ($IPXL) and Director in Aclaris Therapeutics, Inc. ($ACRS) and EVP & CFO in Mallinckrodt plc ($MNK) and Director in Recro Pharma, Inc. ($REPH) and CFO in Amneal Pharmaceuticals, Inc. ($AMRX).

Bryan M. Reasons in Mallinckrodt plc

Trading Symbol: MNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: EVP & CFO
Holdings: 11,593 shares
Current Value: $587,533
Latest Transaction: Dec 07 2020
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Bryan M. Reasons in Mallinckrodt plc

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACRS, AMRX, IPXL, MNK, REPH

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 07 2020MNKMallinckrodt plcReasons Bryan M.EVP & CFOSellS0.175,40089111,59317 K to 11.6 K (-31.78 %)
Apr 03 2020MNKMallinckrodt plcReasons Bryan M.EVP & CFOPayment of ExerciseF1.939861,90316,99318 K to 17 K (-5.48 %)
Jun 07 2019MNKMallinckrodt plcReasons Bryan M.EVP & CFOBuyP8.965,40048,38317,97912.6 K to 18 K (+42.93 %)
Apr 03 2019MNKMallinckrodt plcReasons Bryan M.EVP & CFOOption ExerciseA22.2657,5691,281,48657,569
Apr 03 2019MNKMallinckrodt plcReasons Bryan M.EVP & CFOGrantA0.0012,579012,5790 to 12.6 K

Page:   1